Bharat Immunologicals & Biologicals Corporation Q2 Results

  • BSE: 524663
  • NSE: -
  • ISIN: INE994B01014
  • Sector: Major Drugs
BSE
23.630.01 (0.04%)
Volume31.58 K
Updated: Mon 25 Nov, 2024 | 15:49:10
NSE
This stock is not traded on NSE
Today: 23.26
24.20
52-Wk: 22.25
43.89

Q2 Results Highlights

  • Total Income
    ₹0.00 Cr.
    (NA%)
  • Operating Profit
    ₹-4.72 Cr.
    (8.61%)
  • Profit After Tax
    ₹-4.92 Cr.
    (7.22%)
  • Operating Margin
    NA%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Bharat Immunologicals & Biologicals Corporation Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 23Jun 23QoQ CompSep 22YoY Comp
Total Revenue 0.000.00-%26.48-%
Depreciation/ Amortization 0.030.03-%0.04-%
Other Operating Expenses Total 0.710.42-%0.65-%
Total Operating Expense 4.724.35-%29.02-%
Operating Income -4.72-4.35-%-2.54-%
Net Income Before Taxes -6.65-5.97-%-3.96-%
Net Income -4.92-4.59-%-3.08-%
Diluted Normalized EPS -1.14-1.06-%-0.71-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts